CRBU 250117 1.50P (CRBU250117P1500) Stock Options, News & Quotes

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US OptionsDetailed Quotes

CRBU250117P1500

Watchlist

0.09
0.000.00%

15min DelayClose Jan 2 16:00 ET

0.00High0.00Low

Intraday

5D
Daily

News

Caribou Biosciences Hires CFO From Codexis
WSJJan 2 08:29 ET
Press Release: Caribou Biosciences Appoints Sri Ryali as Chief Financial Officer
Dow JonesJan 2 08:00 ET
Why Is Caribou Biosciences Inc. (CRBU) Among the Top CRISPR Stocks to Invest In?
Yahoo FinanceDec 30, 2024 15:01 ET
Here's Why Caribou Biosciences (NASDAQ:CRBU) Must Use Its Cash Wisely
Yahoo FinanceDec 23, 2024 08:59 ET
Caribou Biosciences (CRBU) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
Yahoo FinanceDec 16, 2024 09:55 ET
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
BenzingaNov 26, 2024 16:06 ET

Comments

Stock_Drift

Sep 25, 2024 08:16

$Caribou Biosciences (CRBU.US)$

FattyChick

Sep 13, 2024 12:24

Next 3 stocks keeping an eye on.

$Caribou Biosciences (CRBU.US)$
$Gossamer Bio (GOSS.US)$
$Archer Aviation (ACHR.US)$
Gonna add a position for each again.

Trytosaveabit

Sep 3, 2024 07:01

News

$Caribou Biosciences (CRBU.US)$ Reuters· just
Caribou Biosciences Announces the FDA Has Granted Fast Track Designations to CB-010 in Refractory Sle and to CB-012 in Relapsed or Refractory Aml

Jaguar8

Jun 2, 2024 20:24

NEWS

$Caribou Biosciences (CRBU.US)$
Caribou Biosciences Presents Encouraging Clinical Data from CB-010 ANTLER Phase 1 Trial in Second-line LBCL Patients at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Caribou Biosciences presented promising clinical data from its CB-010 ANTLER Phase 1 trial at the 2024 ASCO Annual Meeting. CB-010, an allogeneic CAR-T cell therapy with partial HLA matching, showed potential to rival currently approved autologous CAR-T therapies in safety an...

Trytosaveabit

Apr 16, 2024 05:31

Hmm?

$Caribou Biosciences (CRBU.US)$ Got a inverted hammer on the daily! Its wick actually broke above the downtrend continuation wedge! Its Really OS RSI 7 = 14.58! RSI 14 = 24.96! MACD Looks as if its fixing to GC? So lets just see how this turns out? Just thinking outloud